SI1845954T1 - Oralno razpadljiv sestavek olanzapina ali donepezila - Google Patents

Oralno razpadljiv sestavek olanzapina ali donepezila

Info

Publication number
SI1845954T1
SI1845954T1 SI200630726T SI200630726T SI1845954T1 SI 1845954 T1 SI1845954 T1 SI 1845954T1 SI 200630726 T SI200630726 T SI 200630726T SI 200630726 T SI200630726 T SI 200630726T SI 1845954 T1 SI1845954 T1 SI 1845954T1
Authority
SI
Slovenia
Prior art keywords
olanzapine
donepezil
orally disintegrating
disintegrating composition
composition
Prior art date
Application number
SI200630726T
Other languages
English (en)
Inventor
Vesna Kroselj
Sasa Kolaric
Renata Jakse
Miha Vrbinc
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Publication of SI1845954T1 publication Critical patent/SI1845954T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
SI200630726T 2005-01-14 2006-01-13 Oralno razpadljiv sestavek olanzapina ali donepezila SI1845954T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05000664A EP1681048A1 (en) 2005-01-14 2005-01-14 Orally disintegrating composition of olanzapine or donepezil
PCT/EP2006/000284 WO2006074951A2 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil
EP06701464A EP1845954B1 (en) 2005-01-14 2006-01-13 Orally disintegrating composition of olanzapine or donepezil

Publications (1)

Publication Number Publication Date
SI1845954T1 true SI1845954T1 (sl) 2010-08-31

Family

ID=34933289

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630726T SI1845954T1 (sl) 2005-01-14 2006-01-13 Oralno razpadljiv sestavek olanzapina ali donepezila

Country Status (15)

Country Link
EP (2) EP1681048A1 (sl)
AT (1) ATE465719T1 (sl)
AU (1) AU2006205817A1 (sl)
DE (1) DE602006013940D1 (sl)
DK (1) DK1845954T3 (sl)
EA (1) EA013742B1 (sl)
ES (1) ES2344959T3 (sl)
HR (1) HRP20100399T1 (sl)
NO (1) NO20074087L (sl)
PL (1) PL1845954T3 (sl)
PT (1) PT1845954E (sl)
SI (1) SI1845954T1 (sl)
UA (1) UA89394C2 (sl)
WO (1) WO2006074951A2 (sl)
ZA (1) ZA200706692B (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879382B2 (en) 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
US20090208576A1 (en) 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
GB0614586D0 (en) * 2006-07-22 2006-08-30 Pliva Istrazivacki Inst D O O Pharmaceutical Formulation
DK2248519T3 (en) 2006-10-02 2018-01-02 Applied Pharma Res Non-mucoadhesive film dosage forms
EP2076249A2 (en) * 2006-10-27 2009-07-08 FMC Corporation Dry granulation binders, products, and use thereof
EP2133096A4 (en) 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
EP2205213A2 (en) 2007-10-01 2010-07-14 Laboratorios Lesvi, S.L. Orodispersible tablets
CN101756917A (zh) * 2008-10-24 2010-06-30 北京科信必成医药科技发展有限公司 盐酸多奈哌齐口腔崩解片及其制备方法
EP2391350A1 (en) * 2008-12-18 2011-12-07 Ranbaxy Laboratories Limited Atazanavir formulations
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
TR200903293A1 (tr) 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
TR201002084A1 (tr) * 2010-03-19 2011-10-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre
WO2012014012A1 (es) * 2010-07-27 2012-02-02 Laboratorios Andrómaco S.A. Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
BR112014007880B1 (pt) 2011-10-05 2020-07-14 Dupont Nutrition Usa, Inc Composição estab ilizante de celulose microcristalina co-atritada e carboximetilcelulose, método de preparação, e usos
JP6188030B2 (ja) 2011-10-05 2017-08-30 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 微結晶セルロースおよびカルボキシメチルセルロースの安定化剤組成物、該組成物の製造方法並びに食品製品
BR112014013695B1 (pt) 2011-12-09 2020-11-10 DuPont Nutrition USA, Inc. composição estabilizante de atrito simultâneo tendo uma resistência gel superior, método para a produção da composição estabilizante e alimento
WO2014027975A2 (en) * 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CN104510717B (zh) * 2013-09-27 2019-02-05 江苏豪森药业集团有限公司 奥氮平口崩片及其制备方法
CN108261399A (zh) * 2016-12-30 2018-07-10 江苏豪森药业集团有限公司 奥氮平口腔崩解片及其制备方法
CN108926543A (zh) * 2017-05-26 2018-12-04 万全万特制药江苏有限公司 一种奥氮平口腔崩解片及其制备方法
CN109498544A (zh) * 2017-09-15 2019-03-22 万全万特制药江苏有限公司 稳定的奥氮平组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1260215B1 (en) * 2000-03-01 2009-07-29 Eisai R&D Management Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
AU2002255196A1 (en) * 2002-04-18 2003-10-27 Dr. Reddy's Laboratories Ltd. Rapidly dispersing solid oral compositions

Also Published As

Publication number Publication date
NO20074087L (no) 2007-10-09
PL1845954T3 (pl) 2010-10-29
EA013742B1 (ru) 2010-06-30
HRP20100399T1 (hr) 2010-09-30
AU2006205817A1 (en) 2006-07-20
WO2006074951A3 (en) 2007-04-26
EP1681048A1 (en) 2006-07-19
EA200701462A1 (ru) 2008-02-28
DK1845954T3 (da) 2010-08-16
ZA200706692B (en) 2008-07-30
UA89394C2 (uk) 2010-01-25
ATE465719T1 (de) 2010-05-15
EP1845954A2 (en) 2007-10-24
DE602006013940D1 (de) 2010-06-10
WO2006074951A2 (en) 2006-07-20
PT1845954E (pt) 2010-08-02
EP1845954B1 (en) 2010-04-28
ES2344959T3 (es) 2010-09-10

Similar Documents

Publication Publication Date Title
SI1845954T1 (sl) Oralno razpadljiv sestavek olanzapina ali donepezila
TW200621313A (en) Pharmaceutical compositions
TW200732296A (en) Novel compounds
WO2007052289A3 (en) Novel dispersible tablet composition
TW200612892A (en) Novel compounds
TW200734311A (en) New compounds
TW200745003A (en) Novel compounds
WO2007058583A3 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2007052023A3 (en) Novel compounds
WO2008076046A8 (en) Novel 2-amino-5, 5-diaryl-imidazol-4-ones
TW200630336A (en) Novel compounds
WO2008002683A3 (en) Polymorphous forms of carvedilol phosphate
TW200621690A (en) Novel compounds
IL190915A0 (en) Dry formulations of aripiprazole
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
ME01172B (me) (2r,4ar,10br)-6-(2,6-dimetoksipiridin-3-il)-9-etoksi-8-metoksi-1,2,3,4,4a,10b-heksahidrofenantridin-2-ol, hci so
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
SI1831239T1 (sl) Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
TW200833371A (en) Process for solid formulations
TW200732345A (en) Niobium compound
WO2008035360A3 (en) Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil
WO2006090265A3 (en) Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions